Document Type
Article
Publication Date
9-8-2022
Abstract
The isolation of an infective pathogen can be challenging in some patients with active, clinically apparent infectious diseases. Despite efforts in the microbiology lab to improve the sensitivity of culture in orthopedic implant-associated infections, the clinically relevant information often falls short of expectations. The management of peri-prosthetic joint infections (PJI) provides an excellent example of the use and benefits of newer diagnostic technologies to supplement the often-inadequate yield of traditional culture methods as a substantial percentage of orthopedic infections are culture-negative. Next-generation sequencing (NGS) has the potential to improve upon this yield. Bringing molecular diagnostics into practice can provide critical information about the nature of the infective organisms and allow targeted therapy in these otherwise challenging situations. This review article describes the current state of knowledge related to the use and potential of NGS to diagnose infections, particularly in the setting of PJIs.
Recommended Citation
Kullar, Ravina; Chisari, Emanuele; Snyder, James; Cooper, Christopher; Parvizi, Javad; and Sniffen, Jason, "Next-Generation Sequencing Supports Targeted Antibiotic Treatment for Culture Negative Orthopedic Infections" (2022). Rothman Institute Faculty Papers. Paper 190.
https://jdc.jefferson.edu/rothman_institute/190
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Language
English
Comments
This article is the author's final published version in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Volume 76, Issue 2, January 2023, Pg. 359 - 364.
The published version is available at https://doi.org/10.1093/cid/ciac733. Copyright © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.